{"id":"https://openalex.org/W2275107161","doi":"https://doi.org/10.1200/jco.1998.16.8.2752","title":"Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.","display_name":"Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.","publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W2275107161","doi":"https://doi.org/10.1200/jco.1998.16.8.2752","mag":"2275107161","pmid":"https://pubmed.ncbi.nlm.nih.gov/9704728"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1998.16.8.2752","doi":"https://doi.org/10.1200/jco.1998.16.8.2752","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.8.2752","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029588412","display_name":"Brendan D. Curti","orcid":"https://orcid.org/0000-0003-3948-2708","observed_orcids":["https://orcid.org/0000-0003-3948-2708"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B D Curti","raw_affiliation_strings":["Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, USA. bcurti@psghs.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, USA. bcurti@psghs.edu","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004037751","display_name":"Augusto C. Ochoa","orcid":"https://orcid.org/0000-0001-6457-8029","observed_orcids":["https://orcid.org/0000-0001-6457-8029"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A C Ochoa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111531266","display_name":"G C Powers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G C Powers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110312614","display_name":"William C. Kopp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W C Kopp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012473434","display_name":"W. Gregory Alvord","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W G Alvord","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113663097","display_name":"John Edward Janik","orcid":"https://orcid.org/0000-0001-9208-9660","observed_orcids":["https://orcid.org/0000-0001-9208-9660"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J E Janik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109813081","display_name":"Barry L. Gause","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B L Gause","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"B Dunn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Dunn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057644717","display_name":"MICHAEL S. KOPRESKI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M S Kopreski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R Fenton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Fenton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028477575","display_name":"Arnold H. Zea","orcid":"https://orcid.org/0000-0002-1272-0027","observed_orcids":["https://orcid.org/0000-0002-1272-0027"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Zea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044582889","display_name":"Claudio Dansky Ullmann","orcid":"https://orcid.org/0009-0009-2137-1170","observed_orcids":["https://orcid.org/0009-0009-2137-1170"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Dansky-Ullmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111790174","display_name":"Stefan Strobl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Strobl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070328271","display_name":"Linda K. Harvey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Harvey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086973652","display_name":"Edward L. Nelson","orcid":"https://orcid.org/0000-0001-7887-032X","observed_orcids":["https://orcid.org/0000-0001-7887-032X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Nelson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007198397","display_name":"Mario Sznol","orcid":"https://orcid.org/0000-0003-4137-9662","observed_orcids":["https://orcid.org/0000-0003-4137-9662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Sznol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039707350","display_name":"Dan L. Longo","orcid":"https://orcid.org/0000-0002-5850-5998","observed_orcids":["https://orcid.org/0000-0002-5850-5998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D L Longo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.675,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.85133453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"16","issue":"8","first_page":"2752","last_page":"2760"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.2224999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/anti-cd3-stimulation","display_name":"anti-CD3 stimulation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/leukapheresis","display_name":"leukapheresis","score":0.800000011920929},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.7559999823570251},{"id":"https://openalex.org/keywords/t-cell-migration","display_name":"T cell migration","score":0.6340000033378601},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8830000162124634},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/t-cell-expansion","display_name":"T cell expansion","score":0.5559999942779541},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9291248321533203},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.7497145533561707},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4604935944080353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.444680392742157},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.4354773759841919},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40151411294937134},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3892630934715271},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.36026373505592346},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33336716890335083},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.1985446810722351}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007937","descriptor_name":"Leukapheresis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.1998.16.8.2752","doi":"https://doi.org/10.1200/jco.1998.16.8.2752","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.8.2752","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:9704728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9704728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1497717843","https://openalex.org/W1802798556","https://openalex.org/W1873141201","https://openalex.org/W1951776719","https://openalex.org/W1960032085","https://openalex.org/W1972064491","https://openalex.org/W1983205909","https://openalex.org/W1989314580","https://openalex.org/W1996032364","https://openalex.org/W2013068560","https://openalex.org/W2027713350","https://openalex.org/W2051168400","https://openalex.org/W2053882094","https://openalex.org/W2086704878","https://openalex.org/W2090929079","https://openalex.org/W2105320220","https://openalex.org/W2109133885","https://openalex.org/W2116293732","https://openalex.org/W2124446900","https://openalex.org/W2171588122","https://openalex.org/W2232500106","https://openalex.org/W2315098267","https://openalex.org/W2415998768"],"related_works":["https://openalex.org/W2051168400","https://openalex.org/W85451257","https://openalex.org/W2060231524","https://openalex.org/W7020067959","https://openalex.org/W1973767304","https://openalex.org/W2252334125","https://openalex.org/W2139754036","https://openalex.org/W7159596722","https://openalex.org/W1998163229","https://openalex.org/W2945446674"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1],"performed":[2,72],"a":[3,162,189,283,292],"phase":[4],"I":[5],"trial":[6],"to":[7,27,73,235,266],"determine":[8],"whether":[9],"in":[10,20,161,166,188,194,201,249,251,256,264,282],"vivo":[11,120,202,250],"expansion":[12,179,204],"of":[13,31,40,104,153,173,177,196,231,262,272,285,295],"activated":[14,118],"CD4+":[15,35,105,114,243,310],"T":[16,36,106,115,158,244],"cells":[17,77,107,116,159,207,234,245],"was":[18,25,47,71,89,108,180,239],"possible":[19],"cancer":[21,252],"patients.":[22,198],"111Indium":[23],"labeling":[24],"used":[26],"observe":[28],"trafficking":[29],"patterns":[30],"the":[32,82,87,95,170,213,270,304,308],"infused":[33],"stimulated":[34],"cells.":[37],"The":[38,113,150,175,199,260],"influence":[39],"cyclophosphamide":[41],"(CTX)":[42],"dosing":[43],"on":[44],"immunologic":[45],"outcome":[46],"also":[48,240],"examined.":[49],"PATIENTS":[50],"AND":[51],"METHODS:":[52],"Patients":[53],"with":[54,121,124,277],"advanced":[55],"solid":[56],"tumors":[57],"or":[58,65,85,92],"non-Hodgkin's":[59,290],"lymphoma":[60],"received":[61,137],"CTX":[62,83,267],"at":[63,298],"300":[64],"1,000":[66],"mg/m2":[67],"intravenously":[68],"(i.v.).":[69],"Leukapheresis":[70],"harvest":[74],"peripheral-blood":[75],"mononuclear":[76],"(PBMCs)":[78],"either":[79,90],"just":[80],"before":[81],"dose,":[84],"when":[86,206],"patient":[88],"entering":[91],"recovering":[93],"from":[94,303],"leukocyte":[96],"nadir":[97],"induced":[98],"by":[99,110,143],"CTX.":[100],"An":[101],"enriched":[102],"population":[103],"obtained":[109],"negative":[111],"selection.":[112],"were":[117,208,228,280],"ex":[119],"anti-CD3,":[122],"cultured":[123],"interleukin-2":[125],"(IL-2)":[126],"for":[127,146],"4":[128],"days,":[129],"and":[130,156,224,289],"adoptively":[131],"transferred.":[132],"After":[133],"adoptive":[134],"transfer,":[135],"patients":[136,211,296],"IL-2":[138],"(9.0":[139],"x":[140],"10(6)":[141],"IU/m2/d)":[142],"continuous":[144],"infusion":[145],"7":[147],"days.":[148],"RESULTS:":[149],"absolute":[151],"number":[152],"CD4+,":[154],"CD4+/DR+,":[155],"CD4+/CD45RO+":[157],"increased":[160,193,257],"statistically":[163],"significant":[164],"fashion":[165],"all":[167],"cohorts":[168],"after":[169],"first":[171],"course":[172],"therapy.":[174],"degree":[176,271],"CD4":[178,203,233,273],"much":[181],"greater":[182],"than":[183],"CD8":[184],"expansion,":[185],"which":[186,254],"resulted":[187],"CD4:CD8":[190,258],"ratio":[191],"that":[192,306],"26":[195],"31":[197],"greatest":[200,309],"occurred":[205],"harvested":[209],"as":[210],"entered":[212],"CTX-induced":[214],"nadir.":[215],"One":[216],"complete":[217],"response":[218],"(CR),":[219],"two":[220],"partial":[221],"responses":[222,227,276],"(PRs),":[223],"eight":[225],"minor":[226],"observed.":[229],"Trafficking":[230],"111Indium-labeled":[232],"subcutaneous":[236],"melanoma":[237,288],"deposits":[238],"documented.":[241],"CONCLUSION:":[242],"can":[246],"be":[247],"expanded":[248],"patients,":[253],"results":[255],"ratios.":[259],"timing":[261],"pheresis":[263],"relation":[265],"administration":[268],"influences":[269],"expansion.":[274,312],"Tumor":[275],"this":[278],"regimen":[279,305],"observed":[281],"variety":[284],"tumors,":[286],"including":[287],"lymphoma;":[291],"high":[293],"percentage":[294],"had":[297],"least":[299],"some":[300],"tumor":[301],"regression":[302],"produced":[307],"T-cell":[311]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}